학술논문
DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study
Document Type
Report
Source
Cancer Reports. November 2022, Vol. 5 Issue 11
Subject
Language
English
Abstract
INTRODUCTION Esophageal cancer (EC) is the eighth most common cancer in the world.[sup.1,2] It is characterized by a poor prognosis, high mortality, and variation in geographical location.[sup.3] It is estimated [...]
: Esophageal cancer (EC) is a common malignancy with a poor prognosis worldwide. There are two core pathways that repair double‐strand breaks, homologous recombination (HR) and non‐homologous end joining (NHEJ) and numerous proteins are recognized that affect the occurrence of HR and NHEJ. Altered DNA damage response (DDR) pathways are associated with cancer susceptibility and affect therapeutic response and resistance in cancers. DDR pathway alterations in EC are still poorly understood. Therefore, the identification of alterations in specific genes in DDR pathways may potentially result in novel treatments for resistant cancers, especially EC. In this review, we aimed to focus on different aspects of DNA damage and repair processes in EC. Also, we reviewed new therapeutic strategies via targeting DNA repair machinery components.
: Esophageal cancer (EC) is a common malignancy with a poor prognosis worldwide. There are two core pathways that repair double‐strand breaks, homologous recombination (HR) and non‐homologous end joining (NHEJ) and numerous proteins are recognized that affect the occurrence of HR and NHEJ. Altered DNA damage response (DDR) pathways are associated with cancer susceptibility and affect therapeutic response and resistance in cancers. DDR pathway alterations in EC are still poorly understood. Therefore, the identification of alterations in specific genes in DDR pathways may potentially result in novel treatments for resistant cancers, especially EC. In this review, we aimed to focus on different aspects of DNA damage and repair processes in EC. Also, we reviewed new therapeutic strategies via targeting DNA repair machinery components.